杜伐单抗加卡铂/紫杉醇后，再用杜伐单抗加或不加奥拉帕利作为子宫内膜癌的一线治疗：DUO-E/GOG-3041/ENGOT-EN10试验中按错配修复状态划分的总生存期和其他次要疗效指标

{"title":"杜伐单抗加卡铂/紫杉醇后，再用杜伐单抗加或不加奥拉帕利作为子宫内膜癌的一线治疗：DUO-E/GOG-3041/ENGOT-EN10试验中按错配修复状态划分的总生存期和其他次要疗效指标","authors":"Jean-Francois Baurain , Hye Sook Chon , Jessica Thomes Pepin , Michael Sundborg , Michael Gold , Byoung-Gie Kim , Stephanie Blank , Ji-Hong Liu , Michael McCollum , Masahiko Mori , Goda Jonuskiene , Kathleen Moore , Zoltan Novak , Pedro Luis Ramos Guette , Charles Andreé Joseph de Pádua , Marta Gil Martin , Matthew Kowgier , Paula Michelle del Rosario , Shannon Westin , Els Van Nieuwenhuysen","doi":"10.1016/j.ygyno.2024.07.092","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as a firstline treatment for endometrial cancer: Overall survival and additional secondary efficacy en‑dpoints by mismatch repair status in the DUO-E/GOG-3041/ENGOT-EN10 Trial\",\"authors\":\"Jean-Francois Baurain , Hye Sook Chon , Jessica Thomes Pepin , Michael Sundborg , Michael Gold , Byoung-Gie Kim , Stephanie Blank , Ji-Hong Liu , Michael McCollum , Masahiko Mori , Goda Jonuskiene , Kathleen Moore , Zoltan Novak , Pedro Luis Ramos Guette , Charles Andreé Joseph de Pádua , Marta Gil Martin , Matthew Kowgier , Paula Michelle del Rosario , Shannon Westin , Els Van Nieuwenhuysen\",\"doi\":\"10.1016/j.ygyno.2024.07.092\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12853,\"journal\":{\"name\":\"Gynecologic oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecologic oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0090825824004475\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0090825824004475","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}